Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | 1 | UK345AA | IM / LL |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 9N9PY | IM / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | MA2483 | IM / RL |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | 2155252 | PO / MO |
Infant received first dose of Rotaviral vaccination above the recommended age <15 weeks. Adverse events: None Treatment: None Outcome: No adverse effects noted; patient asymptomatic at time of report
None reported
None
None
NKDA/NKA